FERRERO, Dario
 Distribuzione geografica
Continente #
NA - Nord America 1.910
EU - Europa 900
AS - Asia 469
AF - Africa 27
SA - Sud America 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.336
Nazione #
US - Stati Uniti d'America 1.874
IT - Italia 329
DE - Germania 175
CN - Cina 158
FR - Francia 94
IN - India 80
VN - Vietnam 60
GB - Regno Unito 55
JP - Giappone 55
KR - Corea 42
PL - Polonia 32
CH - Svizzera 28
CA - Canada 27
TR - Turchia 22
UA - Ucraina 19
ES - Italia 18
GR - Grecia 18
NL - Olanda 18
FI - Finlandia 13
ZA - Sudafrica 13
RU - Federazione Russa 12
AT - Austria 11
RO - Romania 11
SG - Singapore 11
AU - Australia 9
CZ - Repubblica Ceca 9
SE - Svezia 9
TW - Taiwan 9
IE - Irlanda 8
PT - Portogallo 8
AD - Andorra 7
BE - Belgio 6
BR - Brasile 5
CL - Cile 5
MX - Messico 5
CR - Costa Rica 4
DK - Danimarca 4
ID - Indonesia 4
TH - Thailandia 4
HK - Hong Kong 3
HU - Ungheria 3
PE - Perù 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
AR - Argentina 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
LT - Lituania 2
ML - Mali 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PK - Pakistan 1
PS - Palestinian Territory 1
Totale 3.336
Città #
Fairfield 231
Houston 155
Ashburn 151
Woodbridge 120
Santa Cruz 102
Seattle 100
Cambridge 94
Buffalo 92
Ann Arbor 71
Wilmington 63
Torino 55
Dong Ket 45
Treviso 38
Beijing 36
Columbus 35
Pisa 28
Warsaw 28
Chicago 25
Shanghai 25
Los Angeles 24
New York 24
San Diego 23
Bengaluru 22
Las Vegas 21
Mountain View 19
Boardman 16
University Park 15
Wuhan 15
Turin 14
Helsinki 13
Ottawa 13
Tokyo 13
Changsha 12
Collegno 12
Dallas 12
Phoenix 11
Seocho-gu 11
Vienna 11
Genova 10
Istanbul 10
Paris 10
Seoul 10
Rochester 9
Singapore 9
Dublin 8
Milan 8
Muizenberg 8
Nürnberg 8
Clearwater 7
Lake Forest 7
London 7
Taipei 7
Toronto 7
Berlin 6
Boston 6
Florence 6
Hangzhou 6
Leawood 6
Lisbon 6
Nanjing 6
Ankara 5
Chennai 5
Des Moines 5
Guadalajara 5
Hebei 5
Provo 5
Riva 5
Verona 5
Ürümqi 5
Athens 4
Bangkok 4
Bologna 4
Chandler 4
Manchester 4
Perpignan 4
Portland 4
Saint Petersburg 4
San Francisco 4
Stockholm 4
Vercelli 4
Amsterdam 3
Andorra la Vella 3
Atlanta 3
Bari 3
Beachwood 3
Brentwood 3
Brüttisellen 3
Chengdu 3
Copenhagen 3
Dearborn 3
Duncan 3
Easton 3
Fanwood 3
Fuzhou 3
Hanoi 3
Homebush 3
Hyderabad 3
Jackson Heights 3
Jersey City 3
Lima 3
Totale 2.111
Nome #
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?, file e27ce427-0911-2581-e053-d805fe0acbaa 397
Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents, file e27ce432-472a-2581-e053-d805fe0acbaa 363
FLAI induction regimen in elderly patients with acute myeloid leukemia, file e27ce42f-5416-2581-e053-d805fe0acbaa 280
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients, file e27ce42d-4424-2581-e053-d805fe0acbaa 243
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study, file e27ce42d-f1f6-2581-e053-d805fe0acbaa 224
Can pegylated interferon improve the outcome of polycythemia vera patients?, file e27ce42b-c424-2581-e053-d805fe0acbaa 173
Anemia in the Elderly: not Always what it Seems., file e27ce42b-cfd6-2581-e053-d805fe0acbaa 164
Ruxolitinib in steroid refractory graft-vs.-host disease: A case report, file e27ce429-fbaf-2581-e053-d805fe0acbaa 159
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib, file e27ce42f-09e8-2581-e053-d805fe0acbaa 153
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome, file e27ce42a-1d2a-2581-e053-d805fe0acbaa 139
Effects of erythropoiesis-stimulating agents on overall survival of international prognostic scoring system low/intermediate-1 risk, transfusion-inde-pendent myelodysplastic syndrome patients: A cohort study, file e27ce42e-58a4-2581-e053-d805fe0acbaa 102
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia, file e27ce42e-1c4c-2581-e053-d805fe0acbaa 101
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML, file e27ce42f-4c8e-2581-e053-d805fe0acbaa 98
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients, file e27ce42f-87c9-2581-e053-d805fe0acbaa 96
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis, file e27ce42f-4a50-2581-e053-d805fe0acbaa 95
Corticosteroids can reverse severe imatinib-induced hepatotoxicity, file e27ce426-9ed4-2581-e053-d805fe0acbaa 88
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial, file e27ce42f-5796-2581-e053-d805fe0acbaa 78
Real life use of bendamustine in elderly patients with lymphoid neoplasia, file e27ce432-2046-2581-e053-d805fe0acbaa 74
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib, file e27ce42e-42b5-2581-e053-d805fe0acbaa 68
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment., file e27ce42b-4011-2581-e053-d805fe0acbaa 54
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation, file e27ce432-8806-2581-e053-d805fe0acbaa 51
Differences among young adults, adults and elderly chronic myeloid leukemia patients., file e27ce42a-c137-2581-e053-d805fe0acbaa 45
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice, file e27ce430-0dcb-2581-e053-d805fe0acbaa 45
In patients with Polycythemia Vera older age is the prognostic factor at highest impact on survival, file e27ce427-0f45-2581-e053-d805fe0acbaa 41
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA, file e27ce426-ff24-2581-e053-d805fe0acbaa 31
Hematopoietic stem and progenitor cell composition in peripheral blood and in mobilized CD34+ cells harvests., file e27ce427-5214-2581-e053-d805fe0acbaa 24
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia, file e27ce432-4cb5-2581-e053-d805fe0acbaa 21
Evolving therapeutic approaches for older patients with acute myeloid leukemia in 2021, file e27ce434-db3d-2581-e053-d805fe0acbaa 18
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice, file e27ce432-4903-2581-e053-d805fe0acbaa 13
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia, file e27ce433-4b6f-2581-e053-d805fe0acbaa 11
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study, file e7fe1f2e-1278-4f69-83cb-6ddec4ced9f7 7
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation, file e27ce430-1511-2581-e053-d805fe0acbaa 6
Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia, file e27ce42f-a1ee-2581-e053-d805fe0acbaa 5
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment., file e27ce427-0913-2581-e053-d805fe0acbaa 3
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study., file e27ce42a-ac7f-2581-e053-d805fe0acbaa 2
FLAI induction regimen in elderly patients with acute myeloid leukemia, file b1eb6360-1246-4aaa-b6df-7f4de75b613b 1
In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy., file e27ce426-a007-2581-e053-d805fe0acbaa 1
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia., file e27ce42a-a41a-2581-e053-d805fe0acbaa 1
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series, file e27ce42e-1da5-2581-e053-d805fe0acbaa 1
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline, file e27ce42f-7508-2581-e053-d805fe0acbaa 1
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?, file e27ce432-d349-2581-e053-d805fe0acbaa 1
Totale 3.478
Categoria #
all - tutte 5.540
article - articoli 0
book - libri 0
conference - conferenze 169
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 0 0 0 0 0 0 0 0 58
2019/2020598 40 30 21 54 26 31 36 47 167 52 43 51
2020/2021730 48 66 47 49 50 69 25 108 37 70 64 97
2021/2022827 92 75 37 125 81 18 64 44 41 54 134 62
2022/2023531 24 54 117 82 34 45 30 29 30 28 51 7
2023/2024344 20 35 35 8 27 23 57 26 12 31 62 8
Totale 3.478